VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice

• Jesse M. Damsker ,

  * E-mail: Jesse.Damsker@reveragen.com

  Affiliation ReveraGen BioPharma, Rockville, Maryland, United States of America

  ⨯
• Blythe C. Dillingham,

  Affiliations ReveraGen BioPharma, Rockville, Maryland, United States of America, Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Mary C. Rose,

  Affiliations Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Department of Integrative Systems Biology, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington DC, United States of America

  ⨯
• Molly A. Balsley,

  Affiliation Department of Microbiology, Immunology, and Tropical Medicine, the George Washington University Medical Center, Washington DC, United States of America

  ⨯
• Christopher R. Heier,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Alan M. Watson,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Erik J. Stemmy,

  Affiliation Department of Microbiology, Immunology, and Tropical Medicine, the George Washington University Medical Center, Washington DC, United States of America

  ⨯
• Roslyn A. Jurjus,

  Affiliation Department of Microbiology, Immunology, and Tropical Medicine, the George Washington University Medical Center, Washington DC, United States of America

  ⨯
• Tony Huynh,

  Affiliations Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Endocrine Research Unit and the Australian National University Medical School, The Canberra Hospital, Australian Capital Territory, Australia

  ⨯
• Kathleen Tatem,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Kitipong Uaesoontrachoon,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Dana M. Berry,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Angela S. Benton,

  Affiliation Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America

  ⨯
• Robert J. Freishtat,

  Affiliations Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Department of Integrative Systems Biology, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington DC, United States of America

  ⨯
• Eric P. Hoffman,

  Affiliations ReveraGen BioPharma, Rockville, Maryland, United States of America, Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Department of Integrative Systems Biology, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington DC, United States of America

  ⨯
• John M. McCall,

  Affiliations ReveraGen BioPharma, Rockville, Maryland, United States of America, PharMac LLC, Boca Grande, Florida, United States of America

  ⨯
• Heather Gordish-Dressman,

  Affiliations Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Department of Integrative Systems Biology, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington DC, United States of America

  ⨯
• Stephanie L. Constant,

  Affiliation Department of Microbiology, Immunology, and Tropical Medicine, the George Washington University Medical Center, Washington DC, United States of America

  ⨯
• Erica K. M. Reeves,

  Affiliation ReveraGen BioPharma, Rockville, Maryland, United States of America

  ⨯
•  [ ... ],
• Kanneboyina Nagaraju

  Affiliations ReveraGen BioPharma, Rockville, Maryland, United States of America, Research Center for Genetic Medicine, Children's National Medical Center, Washington DC, United States of America, Department of Integrative Systems Biology, Children's National Medical Center and George Washington University School of Medicine and Health Sciences, Washington DC, United States of America

  ⨯
• [ view all ]
• [ view less ]